Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough AlphaFold system, an AI model that stunned the scientific community by accurately predicting the 3D structure of ...

Google Deepmind’s offshoot Isomorphic Labs is about to be a milestone: The first AI developed medication should go into the ...

The RAND Corporation’s report explores eight scenarios showing how artificial general intelligence (AGI) could reshape global ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Scientists May Have Found the Blueprint of the Human Body at the Bottom of the Ocean Donald Trump orders entry fee, DEI ...